NVS (NYSE) - Novartis AG ADR

Exchange: USA Stocks • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: US66987V1098
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland. Web URL: https://www.novartis.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for NVS (NYSE) - Novartis AG ADR


Market Cap in USD 210,611m
Sector Healthcare
Industry Drug Manufacturers-General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1991-11-18


Fundamental 5.65
Dividend 6.98
Performance 5y 6.31
Rel. Performance vs Sector 1.64
Analysts 3.75
Fair Price Total Ret. 98.66
Fair Price DCF todo


Growth TTM 39.76%
CAGR 5y 10.14%
CAGR / Mean Drawdown 5y 1.54
Sharpe Ratio TTM 1.80
Alpha vs SP500 TTM 29.09
Beta vs SP500 5y weekly 0.55
CAPM 6.56%
Average Daily Range 2m 0.93%
Reversal Oscillator 47.19
Volatility GJR Garch 1y 21.48%
Price / SMA 50 -0.38%
Price / SMA 200 7.61%
Current Volume 993.1k
Average Volume 20d 1033k


Yield TTM 3.41%
Yield on Cost 5y 5.51%
Dividends CAGR 5y 4.71%
Consistency of Dividends all time 96.1%